TRCT
ZEPP

Tower Research Capital (TRC)’s Zepp Health ZEPP Stock Holding History

Tower Research Capital (TRC)’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.7K Buy
2,573
+2,198
+586% +$45K ﹤0.01% 3147
2025
Q4 		$10.1K Sell
375
-249
-40% -$8.88K ﹤0.01% 3834
2025
Q3 		$28.6K Buy
+624
New +$18.9K ﹤0.01% 2984
2023
Q3 		– Sell
-584
Closed -$2.66K – 6289
2023
Q2 		$2.66K Buy
584
+256
+78% +$1.29K ﹤0.01% 5171
2023
Q1 		$2K Buy
328
+303
+1,212% +$2.15K ﹤0.01% 5414
2022
Q4 		$0 Buy
+25
New +$134 ﹤0.01% 6464
2022
Q3 		– Sell
-2,212
Closed -$16K – 6556
2022
Q2 		$16K Buy
2,212
+1,570
+245% +$14.5K ﹤0.01% 4032
2022
Q1 		$7K Buy
642
+217
+51% +$3.5K ﹤0.01% 4778
2021
Q4 		$9K Sell
425
-814
-66% -$24.4K ﹤0.01% 4736
2021
Q3 		$39K Buy
1,239
+1,085
+705% +$44.8K ﹤0.01% 3161
2021
Q2 		$8K Sell
154
-376
-71% -$15.7K ﹤0.01% 4514
2021
Q1 		$23K Buy
530
+377
+246% +$21.9K ﹤0.01% 3786
2020
Q4 		$7K Buy
+153
New +$7.63K ﹤0.01% 4508
2020
Q3 		– Sell
-201
Closed -$10K – 5146
2020
Q2 		$10K Sell
201
-755
-79% -$34.8K ﹤0.01% 4024
2020
Q1 		$51K Buy
+956
New +$51.7K ﹤0.01% 1290
2019
Q4 		– Sell
-423
Closed -$17K – 4488
2019
Q3 		$17K Buy
+423
New +$17.8K ﹤0.01% 2581
2019
Q2 		– Sell
-145
Closed -$8K – 4396
2019
Q1 		$8K Buy
145
+51
+54% +$2.75K ﹤0.01% 2829
2018
Q4 		$4K Buy
+94
New +$3.69K ﹤0.01% 3084

Other funds holding ZEPP

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MM
Monolith Management Hong Kong $332M AUM 119.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Tower Research Capital (TRC)'s ZEPP Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Zepp Health (ZEPP) stake by 586% in Q1 2026, buying an estimated $45K and bringing the position to 2,573 shares worth $30.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3147.

Tower Research Capital (TRC) first reported a position in ZEPP in Q4 2018 and has held it in 18 quarters since. The position peaked at $51K in Q1 2020. 32 funds tracked by Wall St. Rank hold ZEPP as of Q1 2026.

  • Tower Research Capital (TRC) held 2,573 shares of Zepp Health worth $30.7K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,198 Zepp Health shares in Q1 2026, an estimated $45K.
  • Zepp Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3147 holding.
  • Tower Research Capital (TRC) first reported a position in Zepp Health in Q4 2018 and has held it in 18 quarters since.
  • Tower Research Capital (TRC)'s Zepp Health position peaked at $51K in Q1 2020.
  • 32 funds tracked by Wall St. Rank held Zepp Health as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.